Biohaven Pharmaceutical Holding Stock Today
| BHVN Stock | USD 38.72 0.89 2.25% |
Performance0 of 100
| Odds Of DistressLess than 7
|
Biohaven Pharmaceutical is selling at 38.72 as of the 25th of April 2024; that is -2.25 percent down since the beginning of the trading day. The stock's open price was 39.61. Biohaven Pharmaceutical has only a 7 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Equity ratings for Biohaven Pharmaceutical Holding are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2023 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 23rd of September 2022 | Category Healthcare | Classification Health Care |
Biohaven Ltd., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases in the United States. Biohaven Ltd. is a subsidiary of Biohaven Pharmaceutical Holding Company Ltd. The company has 88.26 M outstanding shares of which 8.57 M shares are currently shorted by private and institutional investors with about 5.16 trading days to cover. More on Biohaven Pharmaceutical Holding
Moving together with Biohaven Stock
| 0.63 | ENVB | Enveric Biosciences Financial Report 20th of May 2024 | PairCorr |
| 0.77 | BMY | Bristol Myers Squibb Earnings Call Today | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 10th of May 2024
Biohaven Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biohaven Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biohaven Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Vlad Coric | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Biohaven Pharmaceutical report their recommendations after researching Biohaven Pharmaceutical's financial statements, talking to executives and customers, or listening in on Biohaven Pharmaceutical's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Biohaven Pharmaceutical. The Biohaven consensus assessment is calculated by taking the average forecast from all of the analysts covering Biohaven Pharmaceutical. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the analysis of Biohaven Pharmaceutical's profitability, liquidity, and operating efficiency, Biohaven Pharmaceutical Holding may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of Biohaven Pharmaceutical is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biohaven Pharmaceutical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Biohaven Pharmaceutical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Biohaven Pharmaceutical's financial leverage. It provides some insight into what part of Biohaven Pharmaceutical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biohaven Pharmaceutical Holding (BHVN) is traded on New York Stock Exchange in USA. It is located in 215 Church Street, New Haven, CT, United States, 06510 and employs 239 people. Biohaven Pharmaceutical is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biohaven Pharmaceutical's market, we take the total number of its shares issued and multiply it by Biohaven Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biohaven Pharmaceutical conducts business under Biotechnology sector and is part of Health Care industry. The entity has 88.26 M outstanding shares of which 8.57 M shares are currently shorted by private and institutional investors with about 5.16 trading days to cover.
Biohaven Pharmaceutical Holding currently holds about 23.21 M in cash with (331.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.48.
Check Biohaven Pharmaceutical Probability Of Bankruptcy
Ownership AllocationBiohaven Pharmaceutical retains a total of 88.26 Million outstanding shares. The majority of Biohaven Pharmaceutical Holding outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Biohaven Pharmaceutical to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Biohaven Pharmaceutical. Please pay attention to any change in the institutional holdings of Biohaven Pharmaceutical Holding as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Biohaven Ownership Details
Biohaven Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Biohaven Pharmaceutical jumping above the current price in 90 days from now is about 98.0%. The Biohaven Pharmaceutical Holding probability density function shows the probability of Biohaven Pharmaceutical stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.8246 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Biohaven Pharmaceutical will likely underperform. Additionally, biohaven Pharmaceutical Holding has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Biohaven Pharmaceutical to move above the current price in 90 days from now is about 98.0 (This Biohaven Pharmaceutical Holding probability density function shows the probability of Biohaven Stock to fall within a particular range of prices over 90 days) .
Biohaven Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Biohaven Pharmaceutical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Biohaven Pharmaceutical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Biohaven Pharmaceutical's value.| Instituion | Recorded On | Shares | |
| Perceptive Advisors Llc | 2023-12-31 | 1.7 M | |
| Vanguard Group Inc | 2023-12-31 | 1.7 M | |
| Armistice Capital, Llc | 2023-12-31 | 1.5 M | |
| Geode Capital Management, Llc | 2023-12-31 | 1.4 M | |
| Avidity Partners Management Lp | 2023-12-31 | 1.1 M | |
| Bellevue Group Ag | 2023-12-31 | 1.1 M | |
| Point72 Asset Management, L.p. | 2023-09-30 | 1 M | |
| Farallon Capital Management, L.l.c. | 2023-12-31 | 750 K | |
| Woodline Partners Lp | 2023-12-31 | 743.1 K | |
| Stifel Financial Corp | 2023-12-31 | 6.2 M | |
| Hhg Plc | 2023-12-31 | 5.9 M |
Biohaven Pharmaceutical Historical Income Statement
Biohaven Pharmaceutical Holding Income Statement is one of the three primary financial statements used for reporting Biohaven's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Biohaven Pharmaceutical revenue and expense. Biohaven Pharmaceutical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Biohaven Pharmaceutical's Total Other Income Expense Net is very stable compared to the past year. As of the 25th of April 2024, Reconciled Depreciation is likely to grow to about 7.3 M, while Interest Expense is likely to drop (1.3 M). View More FundamentalsBiohaven Stock Against Markets
Picking the right benchmark for Biohaven Pharmaceutical stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biohaven Pharmaceutical stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biohaven Pharmaceutical is critical whether you are bullish or bearish towards Biohaven Pharmaceutical Holding at a given time. Please also check how Biohaven Pharmaceutical's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biohaven Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Biohaven Pharmaceutical Corporate Directors
Biohaven Pharmaceutical corporate directors refer to members of a Biohaven Pharmaceutical board of directors. The board of directors generally takes responsibility for the Biohaven Pharmaceutical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Biohaven Pharmaceutical's board members must vote for the resolution. The Biohaven Pharmaceutical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| John Childs | Independent Director | Profile | |
| Robert Hugin | Independent Director | Profile | |
| Michael Heffernan | Lead Independent Director | Profile | |
| Julia Gregory | Independent Director | Profile |
How to buy Biohaven Stock?
Before investing in Biohaven Pharmaceutical, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Biohaven Pharmaceutical. To buy Biohaven Pharmaceutical stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Biohaven Pharmaceutical. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Biohaven Pharmaceutical stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Biohaven Pharmaceutical Holding stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Biohaven Pharmaceutical Holding stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Biohaven Pharmaceutical Holding, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Biohaven Stock please use our How to Invest in Biohaven Pharmaceutical guide.
Already Invested in Biohaven Pharmaceutical Holding?
The danger of trading Biohaven Pharmaceutical Holding is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biohaven Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biohaven Pharmaceutical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biohaven Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Biohaven Pharmaceutical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biohaven Pharmaceutical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biohaven Pharmaceutical Holding Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biohaven Pharmaceutical Holding Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biohaven Pharmaceutical Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Biohaven Stock analysis
When running Biohaven Pharmaceutical's price analysis, check to measure Biohaven Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biohaven Pharmaceutical is operating at the current time. Most of Biohaven Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Biohaven Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biohaven Pharmaceutical's price. Additionally, you may evaluate how the addition of Biohaven Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Biohaven Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.73) | Return On Assets (0.46) | Return On Equity (0.84) |
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.